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Objectives: An outbreak of measles symptoms occurring in children in Banjarmasin, South Kalimantan,
Indonesia in 2014 was investigated.
Methods: Nasal swabs were collected from 23 children (median age 41 months) with fever and other
symptoms of measles hospitalized in Ulin General Hospital and Islamic Hospital, Banjarmasin, South
Kalimantan. Viral RNA was extracted for cDNA synthesis, followed by PCR and sequencing using
paramyxovirus family consensus and N-gene primers.
Results: Sixteen measles-positive patients (70%) were identiﬁed. Fifteen virus strains belonged to
genotype D8 and the remaining one strain was conﬁrmed as belonging to genotype D9.
Conclusion: Measles virus genotype D8 was detected in an outbreak of measles in South Kalimantan,
Indonesia, in 2014.
 2016 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
Measles is an acute, highly contagious illness caused by an
enveloped virus in the family Paramyxoviridae, genus
Morbillivirus. Measles is a vaccine-preventable disease, and the
currently available vaccine is expected to provide protection
against all circulating strains.
Three genotypes of measles have previously been reported to
circulate in Indonesia: genotypes G2, G3, and D9.1 The Ministry of
Health, Republic of Indonesia reported that measles vaccination
coverage of children was 94.7% in 2014, but 69.5% in South
Kalimantan Province.2 Despite vaccination efforts in Indonesia, a
total of 12 943 measles cases were reported in 2014, which was an
increase from the 11 521 cases reported in 2013; the incidence rate
(IR) was 5.13/100 000 in 2014 and 4.64/100 000 in 2013.2 An
investigation of the virus responsible for an outbreak involving
children with measles symptoms in Banjarmasin, South Kaliman-
tan is reported herein.* Corresponding author.
E-mail address: safari@eijkman.go.id (D. Safari).
http://dx.doi.org/10.1016/j.ijid.2016.10.029
1201-9712/ 2016 The Author(s). Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).2. Methods
Nasal swabs were collected in viral transport medium (VTM)
from children presenting with fever and other symptoms of
measles. Samples were taken <5 days after illness onset from
patients who were hospitalized in the pediatric wards of Ulin
General Hospital and Islamic Hospital, Banjarmasin, South
Kalimantan, from October to November 2014. A history of travel
or any contact with travelers was not reported for any of the
patients. The testing of outbreak specimens was approved by the
Eijkman Institute Research Ethics Commission (number 66,
November 18, 2013).
Detection of the virus causing the outbreak was conducted as
part of ongoing research into a fever study algorithm, designed for
the surveillance of viruses of pandemic potential (USAID PREDICT
Project). Viral RNAwas extracted fromall nasal swab specimens for
cDNA synthesis, followed by PCR ampliﬁcation using paramyxovi-
rus family consensus primers.3 Positive ampliconswere sequenced
using the Sanger method and a BLAST search was performed in the
GenBank database. All positive samples, as identiﬁed by sequenc-
ing, went through further ampliﬁcation and sequencing of
450 nucleotides in the N-gene region recommended for measles
virus genotyping, following the procedure described by Chibociety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
E. Hartoyo et al. / International Journal of Infectious Diseases 54 (2017) 1–32et al.4 All positive samples were sent to PT Bio Farma, the World
Health Organization (WHO) reference laboratory located in West
Java, Indonesia, for sequence conﬁrmation.
3. Results
During the outbreak, 23 swabs were collected from as many
patients. These patients ranged in age from 6 months to 11 years
[(Figure_1)TD$FIG]Figure 1. Phylogenetic tree ofmeasles virus sequences from the outbreak in Banjarmasin
obtained from the GenBank database and aWHO reference strain). Accession numbers ar
C-terminal hypervariable region of the N-gene recommended formeasles genotyping. Th
the neighbor-joining model and the Kimura 2-parameter method with 1000 bootstrap(median age 41 months); 11 were male and 12 were female.
Clinical presentations included fever (n = 23, 100%), severe rash
typical of measles (n = 21, 91%), cough (n = 23, 100%), nausea and
vomiting (n = 15, 65%), sore throat (n = 16, 70%), stomach ache
(n = 4, 17%), and seizures (n = 2, 9%). All patients recoveredwithout
further complications and were discharged an average of 2.8 days
after hospitalization. The vaccination status of the patients was
determined through a review of the records and parental report,and other genotypeD8 strains circulating in the region (a total of 19 reference strains
e given on the phylogenetic tree. The sequences cover 450 nucleotides encoding the
e phylogenetic tree was constructed using Geneious software version 8.1.5, applying
replicates.
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vaccination status was uncertain for two patients.
Sixteen of the patients were found to be positive for measles. PT
Bio Farma conﬁrmed 15 virus strains to be genotype D8 and one
strain to be genotype D9. The sequences of the D8 strains were 99%
similar to other D8 strains circulating in the region (Figure 1). All
sequence data for the genotype D8 strains reported in this study
have been deposited in GenBank (gene accession numbers
KT964105–KT964119).
4. Discussion
Up until 2009, measles outbreaks in Indonesia were associated
with genotypesG2, G3, andD9.1 [5_TD$DIFF]Measles genotypeD8 (MV-D8) has
already been reported to be circulating and is associated with
sporadic cases in many countries in the Southeast Asia region,
including Thailand, Vietnam, Nepal, India, and Bangladesh.1
Recently, MV-D8 was reported in two Taiwanese travelers visiting
Indonesia.5 According to a WHO report6 and personal communi-
cationwith an IndonesianMinistry of Health representative and PT
Bio Farma, MV-D8 was detected co-circulating with genotypes D9
and B3 in 2013 and 2014 in Sumatera and Jakarta, Indonesia. It is
possible thatMV-D8 has been circulatingwithin Indonesia in areas
of low vaccination coverage, but the origin of the strain is difﬁcult
to specify.
Measles vaccination coverage for children in South Kalimantan
has been reported to be 69.5%, with two doses given as part of the
national immunization program (one at 9 months and one at
24 months of age). This is lower than the minimum vaccination
coverage required to protect the population from a large outbreak,
which is >93–95% of the population immunized.7 This coverage
can be improved through more active, routine vaccination and/or
campaigns aimed at providing the two doses of vaccine.8 Failure to
maintain coveragewith the vaccinationwill lead to a resurgence of
measles.8 Moreover, the interval between the ﬁrst and second dose
of the vaccine will leave several birth cohorts protected with only
one dose, which has only about 85% protection efﬁcacy.9
According to RISKESDAS, a health survey performed by the
Indonesian Ministry of Health in 2007, 2010, 2013, and 2014,
measles vaccination coverage for babies 12–23 months of age in
South Kalimantan decreased from 81.7% to 75.2%, 74.1%, and then
69.5%, respectively.2,10–12 This decrease in vaccination coverage
might have an impact on the occurrence of measles outbreaks.
This study has some limitations. Serum samples were not
available from any of the patients to assess their immunity status.
The breakthrough infection in 11 cases could have been due to the
children only having received one dose of the vaccine and to the
variability in immune response to the measles vaccine.13
The recovery of MV-D8 from an outbreak in Banjarmasin, South
Kalimantan is reported. This information might be beneﬁcial for
directing public health action in Indonesia and for informing
strategies to increase vaccine coverage. The results should alert the
responsible health authorities to increase measles surveillance, aswell as to determine the immunity status among vaccinated
children in order to assess the effectiveness of the measles vaccine
and the measles elimination program.
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